Disease characteristics, early effectiveness, and safety of vestronidase alfa for the treatment of mucopolysaccharidosis type VII (MPS VII) assessed in a novel, longitudinal, multicenter Disease Monitoring Program (DMP)

Autor: Lau, Heather, Gonzalez-Meneses, Antonio, Scarpa, Maurizio, Hostutler, Robert, Zhang, Lin, Malkus, Betsy, Ramirez, Antonio Nino, Marsden, Deborah, Giugliani, Roberto
Zdroj: In Molecular Genetics and Metabolism February 2021 132(2):S63-S63
Databáze: ScienceDirect